Tumor Biomarker Test Market – Global Outlook and Forecast 2022-2028

This report contains market size and forecasts of Tumor Biomarker Test in Global, including the following market information:

Global Tumor Biomarker Test Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Tumor Biomarker Test market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Prostate Specific Antigen Tests Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Tumor Biomarker Test include Abbott Laboratories, Inc., Agilent Technologies, AstraZeneca, Becton Dickinson & Co., Biocept Inc., Cancer Genetics Inc., Danaher Corporation, Foundation Medicine Inc. and Illumina Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Tumor Biomarker Test companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Tumor Biomarker Test Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Tumor Biomarker Test Market Segment Percentages, by Type, 2021 (%)

Prostate Specific Antigen Tests

CTC Tests

Alpha-Fetoprotein (AFP) Tests

CA Test

HER2 Tests

BRCA Test

Anaplastic Lymphoma Kinase (ALK) Tests

EGFR Mutation Tests

KRAS Test

Others

Global Tumor Biomarker Test Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Tumor Biomarker Test Market Segment Percentages, by Application, 2021 (%)

Lung cancer

Breast cancer

Colorectal

Prostate Cancer

Blood Cancer

Global Tumor Biomarker Test Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Tumor Biomarker Test Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Tumor Biomarker Test revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Tumor Biomarker Test revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Abbott Laboratories, Inc.

Agilent Technologies

AstraZeneca

Becton Dickinson & Co.

Biocept Inc.

Cancer Genetics Inc.

Danaher Corporation

Foundation Medicine Inc.

Illumina Inc.

LabCorp Of America Holdings

Luminex Corporation

Myriad Genetics Inc.

NanoString Technologies Inc.

Table of content

1 Introduction to Research & Analysis Reports
1.1 Tumor Biomarker Test Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tumor Biomarker Test Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tumor Biomarker Test Overall Market Size
2.1 Global Tumor Biomarker Test Market Size: 2021 VS 2028
2.2 Global Tumor Biomarker Test Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Tumor Biomarker Test Players in Global Market
3.2 Top Global Tumor Biomarker Test Companies Ranked by Revenue
3.3 Global Tumor Biomarker Test Revenue by Companies
3.4 Top 3 and Top 5 Tumor Biomarker Test Companies in Global Market, by Revenue in 2021
3.5 Global Companies Tumor Biomarker Test Product Type
3.6 Tier 1, Tier 2 and Tier 3 Tumor Biomarker Test Players in Global Market
3.6.1 List of Global Tier 1 Tumor Biomarker Test Companies
3.6.2 List of Global Tier 2 and Tier 3 Tumor Biomarker Test Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type – Global

CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170 / +91 8087042414
Visit: https://www.grandresearchstore.com/

Similar Reports:

Global Tumor Biomarker Test Market Insights and Forecast to 2028

Global Tumor Biomarker Test Market Size, Status and Forecast 2021-2027

Previous post 2022 Global Nanoclay Industry Status and Prospects Professional Market Research Report Standard Version
Next post 2022 Global Modified Alkyd Resin Industry Status and Prospects Professional Market Research Report Standard Version